Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Pharmaceuticals Other
|SAVA||Cassava Sciences, Inc.||-1.84%||46.30||0.0%||$196.99m|
|VRX||Valeant Pharmaceuticals International, Inc.||-0.04%||28.52||14.1%||$167.82m|
|HZNP||Horizon Therapeutics Plc||0.00%||116.01||5.5%||$139.52m|
|JAZZ||Jazz Pharmaceuticals Plc||0.00%||137.37||2.1%||$78.89m|
|PRGO||Perrigo Co. Plc||0.63%||44.68||6.9%||$71.33m|
|UTHR||United Therapeutics Corp.||0.00%||190.45||14.0%||$71.32m|
|AXSM||Axsome Therapeutics, Inc.||0.00%||39.69||1.8%||$36.14m|
|PCRX||Pacira Biosciences, Inc.||0.00%||52.41||9.8%||$31.18m|
|BHC||Bausch Health Cos., Inc.||-0.04%||28.52||0.0%||$30.38m|
|RVNC||Revance Therapeutics, Inc.||0.00%||14.01||6.1%||$29.90m|
|ENDP||Endo International Plc||0.00%||4.38||8.5%||$28.37m|
Enveric Biosciences, Inc. develops cannabinoid medicines and combination therapies. It is a patient-centric biotechnology company endeavouring to enhance the lives of those who are adversely affected by the side effects of Cancer Treatments. The firm is testing natural compounds, starting with cannabinoids to provide patients and clinicians with novel prescription medicines to serve these unmet medical needs. The company is headquartered in Naples, FL.